US Broker Ratings

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 77% Potential Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare industry, specializing in providing cloud-based solutions for the life sciences sector. With a market capitalization of $28.62..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) stands at the forefront of innovation in the biotechnology sector, leveraging its cutting-edge AOC (antibody oligonucleotide conjugates) platform. This San Diego-based firm is pioneering treatments..

Prestige Consumer Healthcare (PBH) Investor Outlook: A 16.53% Potential Upside Amid Robust Analyst Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) is making waves in the healthcare sector with a compelling growth narrative that should catch the eye of savvy investors. Specializing in over-the-counter (OTC)..

Viatris Inc. (VTRS) Stock Analysis: Healthcare Powerhouse with a 3% Dividend Yield Amidst Mixed Ratings

Viatris Inc. (NASDAQ: VTRS), a significant player in the healthcare sector, is drawing attention from investors with its expansive global footprint and a market capitalization of $18.21 billion. As a..

Sarepta Therapeutics (SRPT) Investor Outlook: Exploring the 20.49% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pivotal player in the biotechnology sector, is capturing attention with a potential upside of 20.49%, according to recent analyst ratings. With a market capitalization..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing Growth with a 7.1% Revenue Boost and Strategic Market Presence

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector, has captured investor attention with its solid revenue growth and expansive global operations. With a market capitalization..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Exploring a 14.59% Upside Potential

Medpace Holdings, Inc. (NASDAQ: MEDP) has captured the attention of investors with its impressive growth metrics and a potential upside of 14.59%, making it a compelling candidate for those looking..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking a Potential 110% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is a compelling entity within the biotechnology sector, engaging in the development of therapies for severe endocrinologic, oncologic, metabolic, and neurologic disorders. Headquartered in Redwood..

Merit Medical Systems (MMSI): Investor Outlook Reveals 27.69% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading player in the medical instruments and supplies industry, offers investors an intriguing proposition with a significant potential upside of 27.69% based on..

Centene Corporation (CNC) Stock Report: Navigating Healthcare with a 23.10% Revenue Growth Boost

Centene Corporation (CNC), a formidable player in the healthcare sector, particularly within the healthcare plans industry, has been capturing investor attention with its robust revenue growth and notable market presence...

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 53% Potential Upside

Investors in the healthcare sector should pay close attention to iRhythm Holdings, Inc. (NASDAQ: IRTC), a company at the forefront of digital healthcare innovation. With a focus on ambulatory cardiac..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 31.92% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, continues to capture investor interest with a compelling potential upside of 31.92%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals..

CVS Health Corporation (CVS) Stock Rating Update: 20.85% Potential Upside Beckons Investors

CVS Health Corporation (NYSE: CVS) presents a compelling case for investors seeking a balanced opportunity in the healthcare sector. With a market capitalization of $99.84 billion, CVS stands as a..

Elevance Health, Inc. (ELV) Stock Analysis: Evaluating a Healthcare Giant’s 11.84% Potential Upside

Elevance Health, Inc. (NYSE: ELV), once known as Anthem, Inc., stands as a behemoth in the healthcare industry with a market capitalization of $76.54 billion. The Indianapolis-based company is a..

Telix Pharmaceuticals (TLX) Stock Analysis: Exploring a Promising 235% Upside Potential

In the dynamic world of biotechnology, Telix Pharmaceuticals Limited (ASX: TLX) stands out as a compelling investment opportunity. With a remarkable potential upside of 235%, this Australian healthcare company is..

Tempus AI, Inc. (TEM) Stock Analysis: Unveiling a 69.23% Potential Upside in Healthcare Innovation

Tempus AI, Inc. (NASDAQ: TEM) is rapidly emerging as a compelling player in the healthcare technology sector, specifically within the health information services industry. With a market capitalization of $9.24..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Deep Dive into Its 26.62% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention with its innovative approach to treating RAS-addicted cancers and its enticing potential upside of 26.62%. As a clinical-stage precision oncology company,..

Option Care Health, Inc. (OPCH) Stock Analysis: A 12.42% Upside Potential Awaits Investors

Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring the 75% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is capturing investor attention with its robust growth trajectory and substantial upside potential. With a current market capitalization..

Guardant Health, Inc. (GH) Stock Analysis: Riding the 19.45% Potential Upside in Precision Oncology

Guardant Health, Inc. (GH) is making waves in the healthcare sector with its innovative approach to diagnostics and research. As a leader in precision oncology, the company provides cutting-edge blood..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds